Eisai Inc.
Drug manufacturer · manufacturer
Unclaimed listing
28
Drug products
3
Therapeutic areas
About
Eisai Inc. is listed in the FDA National Drug Code Directory with 28 marketed products, of which 28 are prescription drugs. Dosage forms include INJECTION, TABLET, SUSPENSION, CAPSULE, KIT. Portfolio includes DEA-scheduled controlled substances.
What Eisai Inc. makes
28 products- Ariceptdonepezil hydrochloride
- Ariceptdonepezil hydrochloride
- Ariceptdonepezil hydrochloride
- Halaveneribulin mesylate
- LEQEMBIlecanemab
- LEQEMBIlecanemab
- LECANEMAB AUTOINJECTORlecanemab-irmb
- LECANEMAB AUTOINJECTORlecanemab-irmb
- DAYVIGOlemborexant
- DAYVIGOlemborexant
- Lenvimalenvatinib
- Lenvimalenvatinib
- Lenvimalenvatinib
- Lenvimalenvatinib
- Lenvimalenvatinib
- Lenvimalenvatinib
- Lenvimalenvatinib
- Lenvimalenvatinib
- Fycompaperampanel
- Fycompaperampanel
- Fycompaperampanel
- Fycompaperampanel
- Fycompaperampanel
- Fycompaperampanel
Page 1 of 2Next ›
Get a price
This listing is unclaimed, so post your requirement and every verified pharmacy licensed in your state will bid.
Request a quoteContact
Email and website are not published in the public registries — they are added when the listing is claimed.
From the FDA NDC Directory, refreshed 2026-08-15.
Is this your business?
Claim the listing to publish your catalog, answer buyer enquiries and bid on sourcing requests.
Claim this listing